APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical and Biopharmaceutical Safety Testing Service

Compare research editions
View pricing & licenses

Selected research

Industry Research

Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Research Report 2026

12 August 2026146 pages

Choose your research edition.

Industry ResearchPharmaceutical and Biopharmaceutical Safety Testing Service Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Pharmaceutical and Biopharmaceutical Safety Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical and Biopharmaceutical Safety Testing Service Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical and Biopharmaceutical Safety Testing Service Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Pharmaceutical and Biopharmaceutical Safety Testing Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Pharmaceutical and Biopharmaceutical Safety Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharmaceutical and Biopharmaceutical Safety Testing Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharmaceutical and Biopharmaceutical Safety Testing Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharmaceutical and Biopharmaceutical Safety Testing Service include Eurofins Scientific, SGS, Q2 Solutions, Samsung Biologics, Texcell, WuXi Biologics, Wuhan Canvest Biotechnology, Centre Testing International (CTI) and Suzhou Liangchen Biotechnology, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Pharmaceutical and Biopharmaceutical Safety Testing Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmaceutical and Biopharmaceutical Safety Testing Service.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Pharmaceutical and Biopharmaceutical Safety Testing Service Market by Company

Eurofins Scientific

SGS

Q2 Solutions

Samsung Biologics

Texcell

WuXi Biologics

Wuhan Canvest Biotechnology

Centre Testing International (CTI)

Suzhou Liangchen Biotechnology

JADE Biomedical

Standard Testing Group

Sino Tech World Biologicals

CAS Testing Technical Services

NTEK

Sino Biological

Miracle Points

Suzhou Cefety Bioscience

Zhejiang Hengyu Biological

Merck

Charles River Laboratories

Sartorius

Pharmaceutical and Biopharmaceutical Safety Testing Service Segment by Type

Raw Materials

Viral Banks

Cell Banks

Others

Pharmaceutical and Biopharmaceutical Safety Testing Service Segment by Application

Pharmaceutical and Biotechnology Companies

CROs and CDMOs

Academic and Research Institutions

Pharmaceutical and Biopharmaceutical Safety Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical and Biopharmaceutical Safety Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical and Biopharmaceutical Safety Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical and Biopharmaceutical Safety Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Pharmaceutical and Biopharmaceutical Safety Testing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Type (2021-2026) Table 7. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Type (2027-2032) Table 9. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Application (2021-2026) Table 11. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Application (2027-2032) Table 13. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Region (2021-2026) Table 16. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Region (2027-2032) Table 18. Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Trends Table 19. Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Drivers Table 20. Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Opportunities and Challenges Table 21. Pharmaceutical and Biopharmaceutical Safety Testing Service Market Restraints Table 22. Global Top Pharmaceutical and Biopharmaceutical Safety Testing Service Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Players (2021-2026) Table 24. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Pharmaceutical and Biopharmaceutical Safety Testing Service, Headquarters and Area Served Table 26. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Pharmaceutical and Biopharmaceutical Safety Testing Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2027-2032) & (US$ Million) Table 45. Eurofins Scientific Company Information Table 46. Eurofins Scientific Business Overview Table 47. Eurofins Scientific Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) & (US$ Million) Table 48. Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 49. Eurofins Scientific Recent Developments Table 50. SGS Company Information Table 51. SGS Business Overview Table 52. SGS Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) & (US$ Million) Table 53. SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 54. SGS Recent Developments Table 55. Q2 Solutions Company Information Table 56. Q2 Solutions Business Overview Table 57. Q2 Solutions Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) & (US$ Million) Table 58. Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 59. Q2 Solutions Recent Developments Table 60. Samsung Biologics Company Information Table 61. Samsung Biologics Business Overview Table 62. Samsung Biologics Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) & (US$ Million) Table 63. Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 64. Samsung Biologics Recent Developments Table 65. Texcell Company Information Table 66. Texcell Business Overview Table 67. Texcell Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) & (US$ Million) Table 68. Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 69. Texcell Recent Developments Table 70. WuXi Biologics Company Information Table 71. WuXi Biologics Business Overview Table 72. WuXi Biologics Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) & (US$ Million) Table 73. WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 74. WuXi Biologics Recent Developments Table 75. Wuhan Canvest Biotechnology Company Information Table 76. Wuhan Canvest Biotechnology Business Overview Table 77. Wuhan Canvest Biotechnology Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) & (US$ Million) Table 78. Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 79. Wuhan Canvest Biotechnology Recent Developments Table 80. Centre Testing International (CTI) Company Information Table 81. Centre Testing International (CTI) Business Overview Table 82. Centre Testing International (CTI) Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) & (US$ Million) Table 83. Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 84. Centre Testing International (CTI) Recent Developments Table 85. Suzhou Liangchen Biotechnology Company Information Table 86. Suzhou Liangchen Biotechnology Business Overview Table 87. Suzhou Liangchen Biotechnology Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) & (US$ Million) Table 88. Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 89. Suzhou Liangchen Biotechnology Recent Developments Table 90. JADE Biomedical Company Information Table 91. JADE Biomedical Business Overview Table 92. JADE Biomedical Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) & (US$ Million) Table 93. JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 94. JADE Biomedical Recent Developments Table 95. Standard Testing Group Company Information Table 96. Standard Testing Group Business Overview Table 97. Standard Testing Group Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) & (US$ Million) Table 98. Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 99. Standard Testing Group Recent Developments Table 100. Sino Tech World Biologicals Company Information Table 101. Sino Tech World Biologicals Business Overview Table 102. Sino Tech World Biologicals Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) & (US$ Million) Table 103. Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 104. Sino Tech World Biologicals Recent Developments Table 105. CAS Testing Technical Services Company Information Table 106. CAS Testing Technical Services Business Overview Table 107. CAS Testing Technical Services Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) & (US$ Million) Table 108. CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 109. CAS Testing Technical Services Recent Developments Table 110. NTEK Company Information Table 111. NTEK Business Overview Table 112. NTEK Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) & (US$ Million) Table 113. NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 114. NTEK Recent Developments Table 115. Sino Biological Company Information Table 116. Sino Biological Business Overview Table 117. Sino Biological Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) & (US$ Million) Table 118. Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 119. Sino Biological Recent Developments Table 120. Miracle Points Company Information Table 121. Miracle Points Business Overview Table 122. Miracle Points Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) & (US$ Million) Table 123. Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 124. Miracle Points Recent Developments Table 125. Suzhou Cefety Bioscience Company Information Table 126. Suzhou Cefety Bioscience Business Overview Table 127. Suzhou Cefety Bioscience Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) & (US$ Million) Table 128. Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 129. Suzhou Cefety Bioscience Recent Developments Table 130. Zhejiang Hengyu Biological Company Information Table 131. Zhejiang Hengyu Biological Business Overview Table 132. Zhejiang Hengyu Biological Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) & (US$ Million) Table 133. Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 134. Zhejiang Hengyu Biological Recent Developments Table 135. Merck Company Information Table 136. Merck Business Overview Table 137. Merck Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) & (US$ Million) Table 138. Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 139. Merck Recent Developments Table 140. Charles River Laboratories Company Information Table 141. Charles River Laboratories Business Overview Table 142. Charles River Laboratories Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) & (US$ Million) Table 143. Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 144. Charles River Laboratories Recent Developments Table 145. Sartorius Company Information Table 146. Sartorius Business Overview Table 147. Sartorius Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) & (US$ Million) Table 148. Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 149. Sartorius Recent Developments Table 150. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Pharmaceutical and Biopharmaceutical Safety Testing Service Product Image Figure 5. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Type: 2025 VS 2032 Figure 7. Raw Materials Product Figure 8. Viral Banks Product Figure 9. Cell Banks Product Figure 10. Others Product Figure 11. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Application: 2025 VS 2032 Figure 13. Pharmaceutical and Biotechnology Companies Product Figure 14. CROs and CDMOs Product Figure 15. Academic and Research Institutions Product Figure 16. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 17. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Region: 2025 VS 2032 Figure 19. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Players in 2025 Figure 20. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Manufacturers Established Date Figure 21. Global Top 5 and 10 Pharmaceutical and Biopharmaceutical Safety Testing Service Players Market Share by Revenue in 2025 Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country (2021-2032) Figure 25. United States Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Canada Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Mexico Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country (2021-2032) Figure 28. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country (2021-2032) Figure 30. Germany Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. France Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. U.K. Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Italy Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Spain Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Russia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Netherlands Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Nordic Countries Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country (2021-2032) Figure 40. China Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Japan Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. South Korea Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. India Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. India Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country (2021-2032) Figure 45. Australia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. China Taiwan Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. Southeast Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. South America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country (2021-2032) Figure 50. Brazil Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Argentina Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Chile Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Colombia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Peru Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. Eurofins Scientific Revenue Growth Rate in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) Figure 56. SGS Revenue Growth Rate in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) Figure 57. Q2 Solutions Revenue Growth Rate in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) Figure 58. Samsung Biologics Revenue Growth Rate in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) Figure 59. Texcell Revenue Growth Rate in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) Figure 60. WuXi Biologics Revenue Growth Rate in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) Figure 61. Wuhan Canvest Biotechnology Revenue Growth Rate in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) Figure 62. Centre Testing International (CTI) Revenue Growth Rate in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) Figure 63. Suzhou Liangchen Biotechnology Revenue Growth Rate in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) Figure 64. JADE Biomedical Revenue Growth Rate in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) Figure 65. Standard Testing Group Revenue Growth Rate in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) Figure 66. Sino Tech World Biologicals Revenue Growth Rate in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) Figure 67. CAS Testing Technical Services Revenue Growth Rate in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) Figure 68. NTEK Revenue Growth Rate in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) Figure 69. Sino Biological Revenue Growth Rate in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) Figure 70. Miracle Points Revenue Growth Rate in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) Figure 71. Suzhou Cefety Bioscience Revenue Growth Rate in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) Figure 72. Zhejiang Hengyu Biological Revenue Growth Rate in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) Figure 73. Merck Revenue Growth Rate in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) Figure 74. Charles River Laboratories Revenue Growth Rate in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026) Figure 75. Sartorius Revenue Growth Rate in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026)

Scope & coverage.

Types
  • Raw Materials
  • Viral Banks
  • Cell Banks
  • Others
Applications
  • Pharmaceutical and Biotechnology Companies
  • CROs and CDMOs
  • Academic and Research Institutions
Companies covered
  • Eurofins Scientific
  • SGS
  • Q2 Solutions
  • Samsung Biologics
  • Texcell
  • WuXi Biologics
  • Wuhan Canvest Biotechnology
  • Centre Testing International (CTI)
  • Suzhou Liangchen Biotechnology
  • JADE Biomedical
  • Standard Testing Group
  • Sino Tech World Biologicals
  • CAS Testing Technical Services
  • NTEK
  • Sino Biological
  • Miracle Points
  • Suzhou Cefety Bioscience
  • Zhejiang Hengyu Biological
  • Merck
  • Charles River Laboratories
  • Sartorius

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Pharmaceutical and Biopharmaceutical Safety Testing Service by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Raw Materials
  5. 2.2.3 Viral Banks
  6. 2.2.4 Cell Banks
  7. 2.2.5 Others
  8. 2.3 Pharmaceutical and Biopharmaceutical Safety Testing Service by Application
  9. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  10. 2.3.2 Pharmaceutical and Biotechnology Companies
  11. 2.3.3 CROs and CDMOs
  12. 2.3.4 Academic and Research Institutions
  13. 2.4 Assumptions and Limitations
3 Pharmaceutical and Biopharmaceutical Safety Testing Service Breakdown Data by Type
  1. 3.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Historic Market Size by Type (2021-2026)
  2. 3.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Forecasted Market Size by Type (2027-2032)
4 Pharmaceutical and Biopharmaceutical Safety Testing Service Breakdown Data by Application
  1. 4.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Historic Market Size by Application (2021-2026)
  2. 4.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Perspective (2021-2032)
  2. 5.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Growth Trends by Region
  3. 5.2.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Pharmaceutical and Biopharmaceutical Safety Testing Service Historic Market Size by Region (2021-2026)
  5. 5.2.3 Pharmaceutical and Biopharmaceutical Safety Testing Service Forecasted Market Size by Region (2027-2032)
  6. 5.3 Pharmaceutical and Biopharmaceutical Safety Testing Service Market Dynamics
  7. 5.3.1 Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Trends
  8. 5.3.2 Pharmaceutical and Biopharmaceutical Safety Testing Service Market Drivers
  9. 5.3.3 Pharmaceutical and Biopharmaceutical Safety Testing Service Market Challenges
  10. 5.3.4 Pharmaceutical and Biopharmaceutical Safety Testing Service Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Pharmaceutical and Biopharmaceutical Safety Testing Service Players by Revenue
  2. 6.1.1 Global Top Pharmaceutical and Biopharmaceutical Safety Testing Service Players by Revenue (2021-2026)
  3. 6.1.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Pharmaceutical and Biopharmaceutical Safety Testing Service Head Office and Area Served
  6. 6.4 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Players, Product Type & Application
  7. 6.5 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Manufacturers Established Date
  8. 6.6 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032)
  2. 7.2 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026)
  4. 7.4 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032)
  2. 8.2 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026)
  4. 8.4 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032)
  2. 9.2 Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032)
  2. 10.2 South America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026)
  4. 10.4 South America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032)
  2. 11.2 Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Eurofins Scientific
  2. 12.1.1 Eurofins Scientific Company Information
  3. 12.1.2 Eurofins Scientific Business Overview
  4. 12.1.3 Eurofins Scientific Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026)
  5. 12.1.4 Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  6. 12.1.5 Eurofins Scientific Recent Developments
  7. 12.2 SGS
  8. 12.2.1 SGS Company Information
  9. 12.2.2 SGS Business Overview
  10. 12.2.3 SGS Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026)
  11. 12.2.4 SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  12. 12.2.5 SGS Recent Developments
  13. 12.3 Q2 Solutions
  14. 12.3.1 Q2 Solutions Company Information
  15. 12.3.2 Q2 Solutions Business Overview
  16. 12.3.3 Q2 Solutions Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026)
  17. 12.3.4 Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  18. 12.3.5 Q2 Solutions Recent Developments
  19. 12.4 Samsung Biologics
  20. 12.4.1 Samsung Biologics Company Information
  21. 12.4.2 Samsung Biologics Business Overview
  22. 12.4.3 Samsung Biologics Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026)
  23. 12.4.4 Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  24. 12.4.5 Samsung Biologics Recent Developments
  25. 12.5 Texcell
  26. 12.5.1 Texcell Company Information
  27. 12.5.2 Texcell Business Overview
  28. 12.5.3 Texcell Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026)
  29. 12.5.4 Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  30. 12.5.5 Texcell Recent Developments
  31. 12.6 WuXi Biologics
  32. 12.6.1 WuXi Biologics Company Information
  33. 12.6.2 WuXi Biologics Business Overview
  34. 12.6.3 WuXi Biologics Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026)
  35. 12.6.4 WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  36. 12.6.5 WuXi Biologics Recent Developments
  37. 12.7 Wuhan Canvest Biotechnology
  38. 12.7.1 Wuhan Canvest Biotechnology Company Information
  39. 12.7.2 Wuhan Canvest Biotechnology Business Overview
  40. 12.7.3 Wuhan Canvest Biotechnology Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026)
  41. 12.7.4 Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  42. 12.7.5 Wuhan Canvest Biotechnology Recent Developments
  43. 12.8 Centre Testing International (CTI)
  44. 12.8.1 Centre Testing International (CTI) Company Information
  45. 12.8.2 Centre Testing International (CTI) Business Overview
  46. 12.8.3 Centre Testing International (CTI) Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026)
  47. 12.8.4 Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  48. 12.8.5 Centre Testing International (CTI) Recent Developments
  49. 12.9 Suzhou Liangchen Biotechnology
  50. 12.9.1 Suzhou Liangchen Biotechnology Company Information
  51. 12.9.2 Suzhou Liangchen Biotechnology Business Overview
  52. 12.9.3 Suzhou Liangchen Biotechnology Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026)
  53. 12.9.4 Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  54. 12.9.5 Suzhou Liangchen Biotechnology Recent Developments
  55. 12.10 JADE Biomedical
  56. 12.10.1 JADE Biomedical Company Information
  57. 12.10.2 JADE Biomedical Business Overview
  58. 12.10.3 JADE Biomedical Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026)
  59. 12.10.4 JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  60. 12.10.5 JADE Biomedical Recent Developments
  61. 12.11 Standard Testing Group
  62. 12.11.1 Standard Testing Group Company Information
  63. 12.11.2 Standard Testing Group Business Overview
  64. 12.11.3 Standard Testing Group Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026)
  65. 12.11.4 Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  66. 12.11.5 Standard Testing Group Recent Developments
  67. 12.12 Sino Tech World Biologicals
  68. 12.12.1 Sino Tech World Biologicals Company Information
  69. 12.12.2 Sino Tech World Biologicals Business Overview
  70. 12.12.3 Sino Tech World Biologicals Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026)
  71. 12.12.4 Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  72. 12.12.5 Sino Tech World Biologicals Recent Developments
  73. 12.13 CAS Testing Technical Services
  74. 12.13.1 CAS Testing Technical Services Company Information
  75. 12.13.2 CAS Testing Technical Services Business Overview
  76. 12.13.3 CAS Testing Technical Services Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026)
  77. 12.13.4 CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  78. 12.13.5 CAS Testing Technical Services Recent Developments
  79. 12.14 NTEK
  80. 12.14.1 NTEK Company Information
  81. 12.14.2 NTEK Business Overview
  82. 12.14.3 NTEK Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026)
  83. 12.14.4 NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  84. 12.14.5 NTEK Recent Developments
  85. 12.15 Sino Biological
  86. 12.15.1 Sino Biological Company Information
  87. 12.15.2 Sino Biological Business Overview
  88. 12.15.3 Sino Biological Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026)
  89. 12.15.4 Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  90. 12.15.5 Sino Biological Recent Developments
  91. 12.16 Miracle Points
  92. 12.16.1 Miracle Points Company Information
  93. 12.16.2 Miracle Points Business Overview
  94. 12.16.3 Miracle Points Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026)
  95. 12.16.4 Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  96. 12.16.5 Miracle Points Recent Developments
  97. 12.17 Suzhou Cefety Bioscience
  98. 12.17.1 Suzhou Cefety Bioscience Company Information
  99. 12.17.2 Suzhou Cefety Bioscience Business Overview
  100. 12.17.3 Suzhou Cefety Bioscience Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026)
  101. 12.17.4 Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  102. 12.17.5 Suzhou Cefety Bioscience Recent Developments
  103. 12.18 Zhejiang Hengyu Biological
  104. 12.18.1 Zhejiang Hengyu Biological Company Information
  105. 12.18.2 Zhejiang Hengyu Biological Business Overview
  106. 12.18.3 Zhejiang Hengyu Biological Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026)
  107. 12.18.4 Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  108. 12.18.5 Zhejiang Hengyu Biological Recent Developments
  109. 12.19 Merck
  110. 12.19.1 Merck Company Information
  111. 12.19.2 Merck Business Overview
  112. 12.19.3 Merck Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026)
  113. 12.19.4 Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  114. 12.19.5 Merck Recent Developments
  115. 12.20 Charles River Laboratories
  116. 12.20.1 Charles River Laboratories Company Information
  117. 12.20.2 Charles River Laboratories Business Overview
  118. 12.20.3 Charles River Laboratories Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026)
  119. 12.20.4 Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  120. 12.20.5 Charles River Laboratories Recent Developments
  121. 12.21 Sartorius
  122. 12.21.1 Sartorius Company Information
  123. 12.21.2 Sartorius Business Overview
  124. 12.21.3 Sartorius Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2021-2026)
  125. 12.21.4 Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  126. 12.21.5 Sartorius Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst